Analysts expect Addus Homecare Co. (NASDAQ:ADUS) to report sales of $139.43 million for the current quarter, Zacks Investment Research reports. Four analysts have issued estimates for Addus Homecare’s earnings, with estimates ranging from $135.76 million to $142.38 million. Addus Homecare reported sales of $108.59 million in the same quarter last year, which indicates a positive year over year growth rate of 28.4%. The company is expected to report its next earnings report on Monday, November 5th.

According to Zacks, analysts expect that Addus Homecare will report full-year sales of $521.39 million for the current year, with estimates ranging from $512.66 million to $526.66 million. For the next financial year, analysts expect that the firm will report sales of $593.74 million, with estimates ranging from $562.66 million to $652.95 million. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that follow Addus Homecare.

Addus Homecare (NASDAQ:ADUS) last released its quarterly earnings data on Tuesday, August 7th. The company reported $0.50 earnings per share for the quarter, missing analysts’ consensus estimates of $0.51 by ($0.01). The company had revenue of $131.24 million for the quarter, compared to analyst estimates of $127.81 million. Addus Homecare had a net margin of 3.43% and a return on equity of 10.45%.

ADUS has been the topic of a number of recent research reports. Stephens lifted their price objective on Addus Homecare from $67.00 to $75.00 and gave the company an “overweight” rating in a report on Tuesday, August 7th. Raymond James initiated coverage on Addus Homecare in a report on Monday, August 20th. They set an “outperform” rating and a $75.00 price objective on the stock. BidaskClub downgraded Addus Homecare from a “buy” rating to a “hold” rating in a report on Friday, August 17th. Cantor Fitzgerald initiated coverage on Addus Homecare in a report on Wednesday, September 12th. They set an “overweight” rating and a $77.00 price objective on the stock. Finally, Jefferies Financial Group initiated coverage on Addus Homecare in a report on Tuesday, August 21st. They set a “buy” rating and a $75.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. Addus Homecare presently has an average rating of “Buy” and a consensus price target of $71.29.

NASDAQ ADUS traded up $1.15 during trading on Friday, reaching $65.05. 89,949 shares of the company traded hands, compared to its average volume of 91,021. The company has a current ratio of 3.09, a quick ratio of 3.09 and a debt-to-equity ratio of 0.53. The company has a market capitalization of $896.00 million, a price-to-earnings ratio of 44.86, a PEG ratio of 2.81 and a beta of -0.54. Addus Homecare has a 1-year low of $30.95 and a 1-year high of $72.55.

In other news, major shareholder Eos Capital Partners Iii L. P sold 1,024,733 shares of the business’s stock in a transaction that occurred on Monday, August 20th. The stock was sold at an average price of $59.00, for a total value of $60,459,247.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 34.80% of the stock is owned by insiders.

Institutional investors and hedge funds have recently made changes to their positions in the company. Northpointe Capital LLC acquired a new position in shares of Addus Homecare in the 2nd quarter worth approximately $1,960,000. Paradigm Capital Management Inc. NY acquired a new position in shares of Addus Homecare in the 2nd quarter worth approximately $2,558,000. ClariVest Asset Management LLC acquired a new position in shares of Addus Homecare in the 2nd quarter worth approximately $3,781,000. Mackay Shields LLC acquired a new position in shares of Addus Homecare in the 2nd quarter worth approximately $464,000. Finally, SG Americas Securities LLC acquired a new position in shares of Addus Homecare in the 2nd quarter worth approximately $118,000. 82.54% of the stock is currently owned by institutional investors and hedge funds.

About Addus Homecare

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.

Recommended Story: Buyback

Get a free copy of the Zacks research report on Addus Homecare (ADUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.